2016 Fiscal Year Final Research Report
Restoring tissue homeostasis by regulating TGF-beta signaling by using macrocyclic peptides
Project/Area Number |
15H06073
|
Research Category |
Grant-in-Aid for Research Activity Start-up
|
Allocation Type | Single-year Grants |
Research Field |
Drug development chemistry
|
Research Institution | University of Tsukuba |
Principal Investigator |
|
Project Period (FY) |
2015-08-28 – 2017-03-31
|
Keywords | macrocyclic peptides / in vitro selection / RaPID system / receptors |
Outline of Final Research Achievements |
TGF-beta signaling is implicated in cancer progression. The goal of this project is to regulate TGF-beta signaling by preventing signal transduction into the cell. We aim to identify a macrocyclic peptide or macrocyclic peptides that bind to the type 1 receptor ALK1 and prevent its interaction with the cytokine BMP and/or the type 2 receptor, thereby blocking signal transduction. After in vitro selection, a promising macrocyclic peptide, ALK1-3R6-5, was identified from a diverse library of over 10^12 unique macrocyclic peptides. Chemical synthesis of ALK1-3R6-5 derivatives is underway.
|
Free Research Field |
Cancer signaling
|